Skip to main content

Impax gets FDA OK for generic Allegra-D

11/16/2010

HAYWARD, Calif. — The Food and Drug Administration has approved a generic treatment made by Impax for seasonal allergies, Impax said Tuesday.


 


The drug maker announced the approval of its generic version of Sanofi-Aventis’ Allegra-D (fexofenadine hydrochloride and pseudoephedrine hydrochloride) tablets in the 60-mg/120-mg strength.


 


 


Because Impax was the first company to file for approval of a generic version of the drug, the FDA has awarded it 180 days of market exclusivity in which to compete directly with the branded version.


 


 


Allegra-D had sales of $214 million during the 12-month period ended in September, according to Wolters Kluwer Health.


 


X
This ad will auto-close in 10 seconds